This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2018 Dec;18(6):581-583.

doi: 10.1080/14737167.2018.1524296. Epub 2018 Sep 28.

Fair global drug pricing

Jonathan D Campbell¹, Zoltán Kaló^{2

3}

Affiliations

Affiliations

¹ a Skaggs School of Pharmacy and Pharmaceutical Sciences , University of Colorado Anschutz Medical Campus , Denver , Colorado , USA.
² b Department of Health Policy and Economics, Institute of Economics, Faculty of Social Sciences , Eötvös Loránd University (ELTE).
³ c Syreon Research Institute.

PMID: 30215535
DOI: 10.1080/14737167.2018.1524296

Editorial

Fair global drug pricing

Jonathan D Campbell et al. Expert Rev Pharmacoecon Outcomes Res. 2018 Dec.

. 2018 Dec;18(6):581-583.

doi: 10.1080/14737167.2018.1524296. Epub 2018 Sep 28.

Authors

Jonathan D Campbell¹, Zoltán Kaló^{2

3}

Affiliations

¹ a Skaggs School of Pharmacy and Pharmaceutical Sciences , University of Colorado Anschutz Medical Campus , Denver , Colorado , USA.
² b Department of Health Policy and Economics, Institute of Economics, Faculty of Social Sciences , Eötvös Loránd University (ELTE).
³ c Syreon Research Institute.

PMID: 30215535
DOI: 10.1080/14737167.2018.1524296

No abstract available

Keywords: Drug pricing; differential pricing; fair pricing; global drug pricing; international drug policy; pharmacoeconomics.

PubMed Disclaimer

Similar articles

Estimated Savings From International Reference Pricing for Prescription Drugs.
Mulcahy AW, Schwam D, Rao P, Rennane S, Shetty K. Mulcahy AW, et al. JAMA. 2021 Nov 2;326(17):1744-1745. doi: 10.1001/jama.2021.13338. JAMA. 2021. PMID: 34505870 Free PMC article.
Value-Based Pricing and State Reform of Prescription Drug Costs.
Hwang TJ, Kesselheim AS, Sarpatwari A. Hwang TJ, et al. JAMA. 2017 Aug 15;318(7):609-610. doi: 10.1001/jama.2017.8255. JAMA. 2017. PMID: 28692713 No abstract available.
Prescription drug prices in the US.
[No authors listed] [No authors listed] Med Lett Drugs Ther. 2017 May 22;59(1521):81-83. Med Lett Drugs Ther. 2017. Corrected and republished in: JAMA. 2018 Mar 13;319(10):1042-1043. doi: 10.1001/jama.2018.1844. PMID: 28520697 Corrected and republished. No abstract available.
Reducing Branded Prescription Drug Prices: A Review of Policy Options.
Alexander GC, Ballreich J, Socal MP, Karmarkar T, Trujillo A, Greene J, Sharfstein J, Anderson G. Alexander GC, et al. Pharmacotherapy. 2017 Nov;37(11):1469-1478. doi: 10.1002/phar.2013. Epub 2017 Oct 17. Pharmacotherapy. 2017. PMID: 28805961 Review.
Barriers to Ensuring Access to Affordable Prescription Drugs.
Mello MM. Mello MM. Annu Rev Pharmacol Toxicol. 2020 Jan 6;60:275-289. doi: 10.1146/annurev-pharmtox-010919-023518. Epub 2019 May 28. Annu Rev Pharmacol Toxicol. 2020. PMID: 31136248 Review.

See all similar articles

Cited by

Escalating costs of innovative medicines: perspective and proposals.
Vallano A, Pontes C. Vallano A, et al. Front Public Health. 2024 Sep 24;12:1449707. doi: 10.3389/fpubh.2024.1449707. eCollection 2024. Front Public Health. 2024. PMID: 39381757 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Atypon
Other Literature Sources
- scite Smart Citations